HOTAIR promotes paclitaxel resistance by regulating CHEK1 in ovarian cancer

被引:0
作者
Jiahong Jiang
Shaohai Wang
Zehua Wang
Jing Cai
Lingling Han
Lisha Xie
Qing Han
Wenwen Wang
Yifan Zhang
Xiaoqi He
Chun Yang
机构
[1] Huazhong University of Science and Technology,Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College
来源
Cancer Chemotherapy and Pharmacology | 2020年 / 86卷
关键词
CHEK1; Drug resistance; HOTAIR; Ovarian cancer; Paclitaxel;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:295 / 305
页数:10
相关论文
共 115 条
[1]  
Parkin DM(2001)Global cancer statistics in the year 2000 Lancet Oncol 2 533-543
[2]  
Cannistra SA(2006)Intraperitoneal chemotherapy comes of age N Engl J Med 354 77-79
[3]  
Young M(2001)Paclitaxel: a pharmacoeconomic review of its use in the treatment of ovarian cancer Pharmacoeconomics 19 1227-1259
[4]  
Plosker GL(2007)HOTAIR lifts noncoding RNAs to new levels Cell 129 1257-1259
[5]  
Woo CJ(2014)Long non-coding RNAs and chromatin modifiers: their place in the epigenetic code Epigenetics 9 21-26
[6]  
Kingston RE(2018)LncRNA HOTAIR regulates CCND1 and CCND2 expression by sponging miR-206 in ovarian cancer Cell Physiol Biochem 49 1289-1303
[7]  
Marchese FP(2018)HOTAIR: an oncogenic long non-coding RNA in human cancer Cell Physiol Biochem 47 893-913
[8]  
Huarte M(2018)Integrated proteomic and transcriptomic analysis reveals long noncoding RNA HOX transcript antisense intergenic RNA (HOTAIR) promotes hepatocellular carcinoma cell proliferation by regulating opioid growth factor receptor (OGFr) Mol Cell Proteomics 17 146-159
[9]  
Chang L(2018)Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/beta-catenin signaling pathways by up-regulating miR-34a Int J Biol Macromol 107 2620-2629
[10]  
Guo R(2016)NF-kappaB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer Oncogene 35 5350-5361